These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 6356902

  • 1. Step II treatment with labetalol for essential hypertension.
    Bloomfield SS, Lucas CP, Gantt CL, Poland MP, Medakovic M.
    Am J Med; 1983 Oct 17; 75(4A):81-6. PubMed ID: 6356902
    [Abstract] [Full Text] [Related]

  • 2. Multiclinic comparison of labetalol to metoprolol in treatment of mild to moderate systemic hypertension.
    Frishman WH, Michelson EL, Johnson BF, Poland MP.
    Am J Med; 1983 Oct 17; 75(4A):54-67. PubMed ID: 6356900
    [Abstract] [Full Text] [Related]

  • 3. Labetalol and hydrochlorothiazide in hypertension. Labetalol/Hydrochlorothiazide Multicenter Study Group.
    Clin Pharmacol Ther; 1985 Jul 17; 38(1):24-7. PubMed ID: 2860990
    [Abstract] [Full Text] [Related]

  • 4. Monotherapy with labetalol in the treatment of mild hypertension: a double-blind study.
    Davidov ME, Moir GD, Poland MP, Maloy J, Medakovic M.
    Am J Med; 1983 Oct 17; 75(4A):47-53. PubMed ID: 6356899
    [Abstract] [Full Text] [Related]

  • 5. The effectiveness of labetalol compared to hydrochlorothiazide in hypertensive black patients.
    Lucas C, Jenkins P, Mendels J, Due D, Forbes WP, Sirgo MA.
    J Natl Med Assoc; 1991 Oct 17; 83(10):866-71. PubMed ID: 1800760
    [Abstract] [Full Text] [Related]

  • 6. Multicenter clinical evaluation of long-term efficacy and safety of labetalol in treatment of hypertension.
    Michelson EL, Frishman WH, Lewis JE, Edwards WT, Flanigan WJ, Bloomfield SS, Johnson BF, Lucas C, Freis ED, Finnerty FA.
    Am J Med; 1983 Oct 17; 75(4A):68-80. PubMed ID: 6356901
    [Abstract] [Full Text] [Related]

  • 7. Concomitant therapy with labetalol and hydrochlorothiazide in moderate to moderately severe essential hypertension.
    Kochar MS, Tyson J, Kalbfleisch JH.
    J Clin Pharmacol; 1985 Sep 17; 25(6):433-6. PubMed ID: 3902912
    [Abstract] [Full Text] [Related]

  • 8. Comparison of labetalol and hydrochlorothiazide in elderly patients with hypertension using 24-hour ambulatory blood pressure monitoring.
    Weidler DJ, Vidt DG, Toth PD, Due DL, Sirgo MA.
    J Clin Pharmacol; 1990 Jun 17; 30(6):524-32. PubMed ID: 2355103
    [Abstract] [Full Text] [Related]

  • 9. Intravenous labetalol in the treatment of severe hypertension and hypertensive emergencies.
    Wilson DJ, Wallin JD, Vlachakis ND, Freis ED, Vidt DG, Michelson EL, Langford HG, Flamenbaum W, Poland MP.
    Am J Med; 1983 Oct 17; 75(4A):95-102. PubMed ID: 6139020
    [Abstract] [Full Text] [Related]

  • 10. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW, Laugerotte A, Wright JM.
    Cochrane Database Syst Rev; 2015 Aug 26; 2015(8):CD007449. PubMed ID: 26306578
    [Abstract] [Full Text] [Related]

  • 11. Safety and efficacy of once-daily carvedilol vs twice-daily labetalol in mild to moderate hypertension.
    Ollivier JP, Durier P, Bussiere JL, Gayet JL.
    Eur J Clin Pharmacol; 1990 Aug 26; 38 Suppl 2():S164-6. PubMed ID: 1974509
    [Abstract] [Full Text] [Related]

  • 12. Combined alpha/beta-blockade versus beta 1-selective blockade in essential hypertension in black and white patients.
    Townsend RR, DiPette DJ, Goodman R, Blumfield D, Cronin R, Gradman A, Katz LA, McCarthy EP, Sopko G.
    Clin Pharmacol Ther; 1990 Dec 26; 48(6):665-75. PubMed ID: 2249378
    [Abstract] [Full Text] [Related]

  • 13. Treatment of severe hypertension with labetalol compared with methyldopa and furosemide. Results of a long-term, double-blind, multicenter trial.
    Wallin JD, Wilson D, Winer N, Maronde RF, Michelson EL, Langford H, Maloy J, Poland M.
    Am J Med; 1983 Oct 17; 75(4A):87-94. PubMed ID: 6356903
    [Abstract] [Full Text] [Related]

  • 14. Comparison of labetalol versus enalapril as monotherapy in elderly patients with hypertension: results of 24-hour ambulatory blood pressure monitoring.
    Applegate WB, Borhani N, DeQuattro V, Kaihlanen PM, Oishi S, Due DL, Sirgo MA.
    Am J Med; 1991 Feb 17; 90(2):198-205. PubMed ID: 1996588
    [Abstract] [Full Text] [Related]

  • 15. Comparison of hydrochlorothiazide and sustained-release diltiazem for mild-to-moderate systemic hypertension.
    Frishman WH, Zawada ET, Smith LK, Sowers J, Swartz SL, Kirkendall W, Lunn J, McCarron D, Moser M, Schnaper H.
    Am J Cardiol; 1987 Mar 01; 59(6):615-23. PubMed ID: 3548301
    [Abstract] [Full Text] [Related]

  • 16. Dose-response evaluation of oral labetalol in patients presenting to the emergency department with accelerated hypertension.
    Gonzalez ER, Peterson MA, Racht EM, Ornato JP, Due DL.
    Ann Emerg Med; 1991 Apr 01; 20(4):333-8. PubMed ID: 2003657
    [Abstract] [Full Text] [Related]

  • 17. Treatment of mild and moderate hypertension with medroxalol, an alpha- and beta-adrenergic antagonist.
    Schechter PJ, Tanskanen A, Tuomilehto J, Koch-Weser J.
    J Cardiovasc Pharmacol; 1982 Apr 01; 4(6):955-9. PubMed ID: 6185788
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the effects of labetalol and hydrochlorothiazide on the ventilatory function of hypertensive patients with mild chronic obstructive pulmonary disease.
    Light RW, Chetty KG, Stansbury DW.
    Am J Med; 1983 Oct 17; 75(4A):109-14. PubMed ID: 6356897
    [Abstract] [Full Text] [Related]

  • 19. Labetalol in the treatment of hypertension in elderly and younger patients.
    Abernethy DR, Bartos P, Plachetka JR.
    J Clin Pharmacol; 1987 Nov 17; 27(11):902-6. PubMed ID: 2892866
    [Abstract] [Full Text] [Related]

  • 20. A controlled trial of labetalol (Trandate), propranolol and placebo in the management of mild to moderate hypertension.
    Pugsley DJ, Nassim M, Armstrong BK, Beilin L.
    Br J Clin Pharmacol; 1979 Jan 17; 7(1):63-8. PubMed ID: 367410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.